No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith News
Reply New Message
Back To Forum List View
Zenith News
3
10BagR
May 04, 2020 04:58PM

I am wondering why Zenith Epigenetics is now paying for touting its Epigenetics technology  via Zacks to the US and CA Investment community unless there is an IPO planning  ?? What would be the point... IMO I would first like to see a BP partnership before a IPO would be an easier sell to the US investment community   

3 Recommendations
Re: Zenith News
5
noretreat
May 05, 2020 05:35PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply